[go: up one dir, main page]

ID25856A - Senyawa-senyawa baru - Google Patents

Senyawa-senyawa baru

Info

Publication number
ID25856A
ID25856A IDW20000145D ID20000145D ID25856A ID 25856 A ID25856 A ID 25856A ID W20000145 D IDW20000145 D ID W20000145D ID 20000145 D ID20000145 D ID 20000145D ID 25856 A ID25856 A ID 25856A
Authority
ID
Indonesia
Prior art keywords
pct
new compounds
sec
date
compounds
Prior art date
Application number
IDW20000145D
Other languages
English (en)
Indonesian (id)
Inventor
Brown Roger
Pairaudeau Garry
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of ID25856A publication Critical patent/ID25856A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
IDW20000145D 1997-07-22 1998-07-15 Senyawa-senyawa baru ID25856A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds

Publications (1)

Publication Number Publication Date
ID25856A true ID25856A (id) 2000-11-09

Family

ID=20407805

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000145D ID25856A (id) 1997-07-22 1998-07-15 Senyawa-senyawa baru

Country Status (21)

Country Link
US (1) US6166022A (fr)
EP (1) EP0998475B1 (fr)
JP (1) JP2001510843A (fr)
KR (1) KR20010022084A (fr)
CN (1) CN1270591A (fr)
AT (1) ATE216390T1 (fr)
AU (1) AU8370798A (fr)
BR (1) BR9811028A (fr)
CA (1) CA2296426A1 (fr)
DE (1) DE69804966T2 (fr)
EE (1) EE200000048A (fr)
HU (1) HUP0003826A3 (fr)
ID (1) ID25856A (fr)
IL (1) IL134111A0 (fr)
IS (1) IS5352A (fr)
NO (1) NO20000313L (fr)
PL (1) PL338181A1 (fr)
SE (1) SE9702774D0 (fr)
SK (1) SK188299A3 (fr)
TR (1) TR200000152T2 (fr)
WO (1) WO1999005144A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
EP1056749B1 (fr) * 1998-02-17 2003-02-19 AstraZeneca UK Limited NOUVEAUX COMPOSES DE TRIAZOLO(4,5-d)PYRIMIDINE
JP2003508511A (ja) * 1999-09-09 2003-03-04 カイロテック・テクノロジー・リミテッド 置換シクロペンテン、その調製、およびキラル骨格のためのその使用
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
AR039558A1 (es) * 2000-08-21 2005-02-23 Inspire Pharmaceuticals Inc Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
WO2005032488A2 (fr) 2003-10-03 2005-04-14 Portola Pharmaceuticals, Inc. Sulfonylurees 2,4-dioxo-3-quinazolinylaryl
US7294635B2 (en) 2003-10-03 2007-11-13 Portola Pharmaceuticals, Inc. Substituted isoquinolinones
ATE469157T1 (de) 2003-10-21 2010-06-15 Inspire Pharmaceuticals Inc Tetrahydrofuroä3,4-düdioxolverbindungen und zusammensetzungen und verfahren zur inhibierung der trombozytenaggregation
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
WO2006039212A2 (fr) 2004-09-29 2006-04-13 Portola Pharmaceuticals, Inc. 2h-1,3-benzoxazin-4(3h)-ones substitues
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
WO2007020935A1 (fr) * 2005-08-17 2007-02-22 Ono Pharmaceutical Co., Ltd. Agent thérapeutique pour soulager la douleur, comprenant un récepteur p2y12 et/ou un bloqueur de récepteur p2y14
EA017402B1 (ru) 2005-11-03 2012-12-28 Портола Фармасьютикалз, Инк. [4-(6-галоген-7-замещенные-2,4-диоксо-1,4-дигидро-2н-хиназолин-3-ил)фенил]-5-хлортиофен-2-илсульфонилмочевины, их формы, способы получения соединений, фармацевтические композиции, содержащие эти соединения, и их применение
WO2008054795A2 (fr) 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Dérivés de triazolopyrimidine convenant comme antagonistes du récepteur p2y12 de l'adp
US9725479B2 (en) 2010-04-22 2017-08-08 Ionis Pharmaceuticals, Inc. 5′-end derivatives
IN2012CN10271A (fr) * 2010-05-27 2015-04-10 Reddy’S Lab Ltd Dr
US9458244B2 (en) 2012-12-28 2016-10-04 Abbvie Inc. Single chain multivalent binding protein compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
CA2154681A1 (fr) * 1993-02-03 1994-08-18 Mark David Erion Inhibiteurs de l'adenosine kinase renfermant des derives lyxofuranosyliques
KR100444123B1 (ko) * 1995-07-11 2004-10-14 아스트라제네카 악티에볼라그 신규한혈소판응집억제제

Also Published As

Publication number Publication date
JP2001510843A (ja) 2001-08-07
CA2296426A1 (fr) 1999-02-04
IL134111A0 (en) 2001-04-30
TR200000152T2 (tr) 2000-07-21
CN1270591A (zh) 2000-10-18
EP0998475A1 (fr) 2000-05-10
SK188299A3 (en) 2000-08-14
ATE216390T1 (de) 2002-05-15
HUP0003826A2 (hu) 2001-04-28
PL338181A1 (en) 2000-10-09
DE69804966D1 (de) 2002-05-23
BR9811028A (pt) 2000-08-01
NO20000313D0 (no) 2000-01-21
US6166022A (en) 2000-12-26
HUP0003826A3 (en) 2001-11-28
EP0998475B1 (fr) 2002-04-17
SE9702774D0 (sv) 1997-07-22
IS5352A (is) 2000-01-19
KR20010022084A (ko) 2001-03-15
WO1999005144A1 (fr) 1999-02-04
DE69804966T2 (de) 2002-11-07
EE200000048A (et) 2000-10-16
NO20000313L (no) 2000-03-22
AU8370798A (en) 1999-02-16

Similar Documents

Publication Publication Date Title
ID25856A (id) Senyawa-senyawa baru
SE9702772D0 (sv) Novel compounds
TR200000197T2 (tr) Yeni bileşimler
EE9900465A (et) Uued ühendid
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
MY118163A (en) Aryl fused azapolycyclic compounds
PT991653E (pt) Novos compostos
SE9504661D0 (sv) New compounds
ATE212993T1 (de) Pyrolopyrimidine und verfahren zu ihrer herstellung
SE9702564D0 (sv) New compounds
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
FI970150A0 (fi) Substituoituja pyrimidiiniyhdisteitä ja niiden käyttö
BG101715A (bg) Тетрациклени спиросъединения,метод за тяхното получаване и приложението им като 5нт долу 1d рецепторни антагонисти
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
SE9702563D0 (sv) Compounds
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
TW369529B (en) 5-heterocyclo-1,5-benzodiazepine derivatives, pharmaceutical composition comprising the same and process for the preparation thereof
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
NO970473L (no) N-substituerte 3-azabicyklo (3.2.0)heptanderivater egnet som neuroleptika
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
MY136138A (en) Hexacyclic compounds
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
SE0004099D0 (sv) Novel compounds
ATE272642T1 (de) Thieno(2,3-d)pyrimidindione und ihre verwendung als pharmazeutische mittel
BG105178A (bg) Нови 2,3,3а,4,9,9а-хексахидро-8-хидрокси-1н-бенз/f/индоли, метод за получаването им и приложението им като лекарствени средства